Proptosis secondary to rosiglitazone treatment
International Journal of Diabetes and Metabolism. 2008; 16 (2): 89-90
en Inglés
| IMEMR
| ID: emr-86869
ABSTRACT
To report a case of new onset proptosis secondary to treatment with rosiglitazone Case report A patient developed symptomatic bilateral proptosis requiring surgical intervention, two years and a half after treatment with rosiglitazone. Asymptomatic eye protrussion is a frequent finding in patients treated with thiazolidinediones. In a few cases, the proptosis may be clinically significant and may present in patients with or without a previous history of thyroid disease
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Enfermedades de la Tiroides
/
Tejido Adiposo
/
Exoftalmia
/
Tiazolidinedionas
/
Receptores Activados del Proliferador del Peroxisoma
/
Insulina
Tipo de estudio:
Informe de Casos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Int. J. Diabetes Metab.
Año:
2008
Similares
MEDLINE
...
LILACS
LIS